Your browser doesn't support javascript.
loading
Berbamine hydrochloride potently inhibits SARS-CoV-2 infection by blocking S protein-mediated membrane fusion.
Zhang, Zhe-Rui; Zhang, Ya-Nan; Zhang, Hong-Qing; Zhang, Qiu-Yan; Li, Na; Li, Qi; Deng, Cheng-Lin; Zhang, Bo; Li, Xiao-Dan; Ye, Han-Qing.
Afiliação
  • Zhang ZR; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Zhang YN; University of Chinese Academy of Sciences, Beijing, China.
  • Zhang HQ; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Zhang QY; University of Chinese Academy of Sciences, Beijing, China.
  • Li N; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Li Q; University of Chinese Academy of Sciences, Beijing, China.
  • Deng CL; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Zhang B; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Li XD; University of Chinese Academy of Sciences, Beijing, China.
  • Ye HQ; Drug Discovery Center for Infectious Disease, Nankai University, Tianjin, People's Republic of China.
PLoS Negl Trop Dis ; 16(4): e0010363, 2022 04.
Article em En | MEDLINE | ID: mdl-35468133
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Benzilisoquinolinas / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Benzilisoquinolinas / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article